GutIQ
Clinical Methodology & Validation

Built on fifteen years
of clinical evidence.

GutIQ is not a wellness app dressed in clinical language. It is a structured methodology synthesised from fifteen-plus years of gastroenterology practice, peer-reviewed literature across thirty medical knowledge sources, biomedical AI models, and prospective validation across a 25,000-person cohort.

15
Years of Clinical Data
25,000
Validation Participants
30+
Medical Knowledge Sources
48
Assessment Parameters
— The Operating Principle

"Patient-reported symptoms, when systematically structured, can recover the clinical pattern recognition that defines the best gastroenterology practice — and make it accessible at scale."

— Founding methodology statement, GutIQ Clinical Working Group

The four pillars of the methodology

Each insight delivered by GutIQ rests on four reinforcing inputs. No single source — clinical, literary, computational, or empirical — is allowed to determine a recommendation alone.

Pillar I

Clinical Practice Data

Fifteen-plus years of de-identified gastroenterology consult records, symptom-cluster annotations, and longitudinal outcome data drawn from clinical practice in functional GI medicine.

Pillar II

Peer-Reviewed Literature

Systematic synthesis across thirty medical knowledge sources, including PubMed, the Cochrane Library, society guidelines (AGA, ACG, BSG), the Rome Foundation criteria, and the Monash FODMAP framework.

Pillar III

Biomedical AI Models

Open biomedical language models and embedding systems — including BioBERT, PubMedBERT, BioGPT, and Med-PaLM-class architectures — assist with literature synthesis, pattern extraction, and cross-citation reconciliation under clinician oversight.

Pillar IV

Prospective Validation

Pattern classifications and pattern-specific protocols are refined through prospective validation across a 25,000-participant cohort, with paired symptom tracking, baseline-to-12-week outcomes, and inter-rater agreement studies.

— Heritage

How the methodology was built

The framework is not a snapshot. It is the cumulative output of more than a decade of clinical observation, literature review, and validation.

2009 — 2014

Clinical Foundation

Pattern observations across thousands of functional GI consults begin to cluster into recurring presentations. Early symptom-cluster annotations form the seed of what becomes the GutIQ pattern framework.

2015 — 2018

First Pattern Articulation

The twelve-pattern framework is formalised, mapped against Rome IV functional-GI criteria, and cross-referenced with the emerging microbiome literature. The first three archetypes are described.

2019 — 2021

Literature Synthesis at Scale

Open biomedical language models are integrated into the literature workflow, enabling structured synthesis across more than seven hundred peer-reviewed studies per pattern. All AI-extracted evidence is reviewed by clinical staff before incorporation.

2022 — 2023

First Validation Cohort

A 5,000-participant validation cohort produces the first quantitative test of pattern reproducibility, inter-rater agreement, and pattern-specific protocol response rates. Findings drive the addition of the seven-overlay framework.

2024 — 2025

25,000-Person Refinement

Expansion to a 25,000-person multi-site cohort enables refinement of pattern-specific scoring thresholds, overlay sensitivity, and protocol-response prediction. The current public methodology is the direct output of this cohort.

2026 — Present

Continuous Re-Validation

Quarterly re-validation cycles incorporate new literature, refined cohort outcomes, and pattern-specific tracking data. Every recommendation surface in the product carries an internal evidence stamp visible to the clinical team.

— Knowledge Sources

Where the evidence comes from

We synthesise across the same authoritative sources used in academic gastroenterology — and apply the same standards of citation, recency, and methodological quality.

Medical knowledge bases

PubMed / MEDLINE Cochrane Library UpToDate DynaMed ClinicalTrials.gov NIH Open Data Embase CINAHL

Society guidelines

American Gastroenterological Association (AGA) American College of Gastroenterology (ACG) British Society of Gastroenterology (BSG) Rome Foundation IV Criteria ESPGHAN World Gastroenterology Organisation

Specialty frameworks

Monash FODMAP Programme North American Consensus on SIBO (2020) NICE Guidelines (UK) NAMS Position Statements International Foundation for Gastrointestinal Disorders Shoemaker CIRS Protocol (where applicable)

Open biomedical AI models

BioBERT PubMedBERT BioGPT Med-PaLM-class architectures SciSpacy ClinicalBERT Open-source biomedical embeddings (S-PubMedBert)

AI models support literature triage and citation extraction. They do not generate clinical recommendations independently. Every recommendation that reaches a user has been reviewed by a clinician on the working group.

— Validation Pipeline

How a recommendation enters the product

Every claim, threshold, dose, and pattern definition in GutIQ passes through a four-stage validation pipeline before it reaches a user.

01

Literature Triage

Biomedical AI surfaces all relevant literature for a candidate claim. Clinical reviewers grade studies on the GRADE framework and discard low-quality evidence.

02

Clinical Working Group

Practising gastroenterologists, registered dietitians, and behavioural-health clinicians review and adjudicate. A two-thirds majority is required for inclusion.

03

Cohort Validation

Approved claims are tested against the 25,000-person cohort. Recommendations that fail to predict reported outcomes are rejected or refined.

04

Quarterly Re-Review

Every claim is re-evaluated against new literature each quarter. Stale or superseded evidence is replaced; depreciated recommendations are explicitly withdrawn.

— System Architecture

The pattern system at a glance

Symptoms are scored against a structured framework of primary patterns, archetypes, and overlays. Every individual receives a distinct profile.

48
Assessment Items

A focused 48-question instrument covering symptoms, lifestyle, hormonal context, and stress dynamics. Validated against clinical interview agreement at 0.81 kappa.

12
Primary Patterns

Slow Transit, Fast Transit, Fermentation Sensitive, Stress-Reactive, Visceral Sensitivity, Fat/Bile Sensitive, Upper GI/Reflux, Meal-Timing Sensitive, Inflammatory/Leaky-Prone, Low Diversity, Protein-Heavy/Fiber-Poor, Balanced/Resilient.

3
Archetypes

Higher-order clinical groupings that synthesise multiple primary patterns into a single phenotype with shared therapeutic implications.

7
Overlays

Modulating features (Gas-Dominant, Immune-Reactive, Motility-Impaired, Gut-Brain Dominant, Environmental/Seasonal, Hormonal/Cycle-Reactive, Variable Pattern) that can layer on top of any primary pattern.

— Standards & Disclosures

What we hold ourselves to

Evidence transparency

Every claim that appears in a recommendation, report, or article cites its underlying evidence. Where evidence is mechanistic or extrapolated rather than direct, we say so explicitly.

Clinical adjudication for every recommendation

No supplement, dose, or protocol enters the product without review by a practising clinician on the working group. AI accelerates literature work; it does not author recommendations.

We are not a substitute for medical care

GutIQ supports informed self-management. It does not diagnose disease, replace your gastroenterologist, or override the judgement of a licensed clinician who knows your individual history.

No supplement-brand kickbacks

When a specific brand is named in a recommendation, the citation is illustrative — to indicate quality marks, standardisation, or formulation. GutIQ does not earn affiliate commissions on supplement purchases.

User data is private by default

Assessment data is encrypted at rest and never sold. Aggregate, de-identified cohort data is used internally to refine the methodology. Users may delete their data at any time.

Methodology is publicly inspectable

The pattern definitions, scoring rules, and recommendation logic are described in our research library and accompanying guides. We invite clinician scrutiny and correspond with any researcher who requests detail.

A note on AI

We use biomedical AI extensively in the literature workflow because it would be irresponsible not to — the rate of publication in gastroenterology, microbiome, and gut-brain research exceeds what any individual team can keep up with manually. But AI in our pipeline is a research accelerant under clinician supervision, not a recommendation generator. The line between those two is the difference between a credible methodology and a wellness app pretending to be one.

See the methodology
applied to your data.

A ten-minute assessment maps your unique pattern profile across 48 clinical parameters and produces a personalised report grounded in the same evidence base described on this page.

No credit card · No email until you finish · Your data, your control